Core Viewpoint - The company is advancing the acquisition of 100% equity in Chongqing New Mile Medical Management Co., Ltd., which is expected to enhance its operational scale and profitability in the healthcare sector [1][2]. Group 1: Acquisition Details - On November 4, the company announced that its shareholders approved the acquisition of Chongqing New Mile Medical Management Co., Ltd. at the fifth extraordinary general meeting of 2024, with 5.93 billion shares voting in favor, representing 76.8% of the valid votes [1]. - The acquisition is strategically important due to Chongqing's economic growth and the company's goal to establish a regional center with revenue between 800 million to 1 billion yuan [1][2]. - The company aims to enhance its business presence in Southwest China, where its previous market share was only 14% [2]. Group 2: Financial Performance - Chongqing New Mile reported revenues of 315 million yuan and 204 million yuan for 2023 and the first seven months of 2024, respectively, with net profits of 1.21 million yuan and 7.43 million yuan [2]. - The company has shown a significant recovery in profitability, achieving a net profit of 156 million yuan in 2022 after restructuring, although it faced a decline in 2023 with a net profit of 31 million yuan, down 80.29% year-on-year [4]. - For the first three quarters of the current year, the company reported revenues of 2.681 billion yuan, a year-on-year increase of 6.93%, and a net profit of 52.79 million yuan, up 57.98% year-on-year [4]. Group 3: Market Confidence and Future Prospects - The high approval rate from minority shareholders for the acquisition reflects confidence in the company's future growth and strategic direction [2]. - The company has initiated a share buyback plan, indicating management's confidence in the company's long-term prospects [2]. - The potential for further asset injections from the controlling shareholder's non-listed segment is anticipated, which could enhance the company's asset base and market position [2].
新里程收购控股股东旗下资产,公司:后续医院资产将持续注入